Benzinga | Jun 17, 2021 10:24AM EDT

Kala Pharmaceuticals Files For U.S. Patent Titled 'Biochemical binding of RET9 and VEGFR2 inhibitors'

https://appft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.html&r=6289&p=126&f=G&l=50&d=PG01&S1=20210617.PD.&OS=PD/20210617&RS=PD/20210617